Differential effects of GLP-1 receptor agonist on foam cell formation in monocytes between non-obese and obese subjects

Metabolism: Clinical and Experimental
Masashi TanakaNoriko Satoh-Asahara

Abstract

Monocytes/macrophages (Mϕ) transform into foam cells in the presence of oxidized-LDL (ox-LDL), releasing inflammatory mediators. The antiatherogenic role of a dipeptidyl peptidase-4 inhibitor is mediated, in part, through improving the unbalance of inflammatory (M1)/anti-inflammatory (M2) phenotypes in monocytes. In this study, we examined differential regulation of glucagon-like peptide-1 receptor (GLP-1R) signaling for antiatherogenesis in monocytes/Mϕ from normal-weight control subjects and obese patients. We evaluated the effects of exendin-4 (Ex-4), a GLP-1R agonist, on ox-LDL-stimulated foam cell formation, M1/M2 cytokine production, and organelle change in primary monocytes from control subjects and obese patients and human monocytic THP-1-derived Mϕ as well. Here we report that Ex-4 suppressed foam cell formation and M1 cytokine expression and, interestingly, induced indicators of autophagy in ox-LDL-stimulated monocytes from control subjects. The suppressing effects on foam cell formation by Ex-4 were reversed by a cAMP inhibitor. In contrast to control subjects, Ex-4 did not induce indicators of autophagy, but did induce foam cell formation and M1 cytokine expression in monocytes from obese patients. GLP-1R expression...Continue Reading

References

Jan 20, 2009·The Journal of Biological Chemistry·Carson C ThoreenNathanael S Gray
Jan 22, 2010·Journal of Leukocyte Biology·Taiese Crystal BinghamBruce N Cronstein
Feb 18, 2010·Proceedings of the American Thoracic Society·Stefan W RyterAugustine M K Choi
Jun 4, 2010·Cell Metabolism·Ling YangGökhan S Hotamisligil
Jul 14, 2011·Autophagy·Hege UglandHeidi Kiil Blomhoff
Oct 21, 2011·The Journal of Clinical Endocrinology and Metabolism·Ajay ChaudhuriParesh Dandona
Feb 1, 2012·Nature Reviews. Cardiology·Jacob SivertsenTina Vilsbøll
Feb 11, 2012·Endocrine Reviews·John R Ussher, Daniel J Drucker
Mar 24, 2012·Cell Metabolism·Babak RazaniClay F Semenkovich
Apr 5, 2012·The Journal of Experimental Medicine·Elizabeth S GoldAlan Aderem
Sep 12, 2012·Autophagy·Daniel J KlionskyBrian Zuckerbraun
Oct 16, 2012·Metabolism: Clinical and Experimental·Noriko Satoh-AsaharaAkira Shimatsu
Apr 23, 2013·Nature Medicine·Yichuan XiaoShao-Cong Sun
May 21, 2013·Cell Metabolism·Jonathan E Campbell, Daniel J Drucker
Sep 3, 2013·The New England Journal of Medicine·William B WhiteUNKNOWN EXAMINE Investigators
Sep 18, 2013·Diabetes, Obesity & Metabolism·K Eguchi, I Manabe
Oct 22, 2013·Metabolism: Clinical and Experimental·Young-Sun Lee, Hee-Sook Jun
Nov 12, 2013·Progress in Neurobiology·Saeid GhavamiMarek J Łos
Feb 19, 2014·Atherosclerosis·Wim MartinetGuido R Y De Meyer
Jun 8, 2014·Current Opinion in Genetics & Development·Jaime L Schneider, Ana Maria Cuervo
Jul 19, 2014·The Journal of Clinical Investigation·Jinyoung KimMyung-Shik Lee
Jul 19, 2014·The Journal of Clinical Investigation·Nayumi ShigiharaHirotaka Watada
Jul 19, 2014·The Journal of Clinical Investigation·Jacqueline F RiveraPeter C Butler
Dec 7, 2014·Cell·Lorenzo GalluzziGuido Kroemer
Jun 9, 2015·The New England Journal of Medicine·Jennifer B GreenUNKNOWN TECOS Study Group

❮ Previous
Next ❯

Citations

Apr 7, 2018·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Edison Goncalves, David S H Bell
Jan 14, 2018·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Yoko IrieUNKNOWN Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) Collaborators
Sep 27, 2019·Pharmacological Reviews·Dongdong WangAtanas G Atanasov
Dec 10, 2020·Journal of Inflammation·Karina Vargas-SánchezMonica Losada-Barragán
Aug 28, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jared BerndtSok Cheon Pak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms